Journavx is the first truly new painkiller approved by the Food and Drug Administration in more than 20 years. But the drug is expensive, and many people can't get it yet.

Analysts questioned whether the complete response letter Replimune received was evidence of changing approval standards at the FDA.

After the FDA’s approval, suzetrigine became the first new painkiller approved in the US in 27 years. Journavx was evaluated in two randomized controlled trials of acute surgical pain.

A meeting held by the FDA Thursday spotlighted debate over black box warnings that have limited use of hormone treatment for ...

D AVENPORT, Iowa (KWQC) - The Food and Drug Administration recently approved Journavx to treat short-term pain. It’s a new class of non-opioid pain medication for treating adults and the first ...

Journavx, which is used to treat pain, can cause side effects. ... If you develop a side effect while taking Journavx and want to tell the FDA about it, visit MedWatch or call 800-FDA-1088.

Learn about the dosage for Journavx in treating acute pain in adults. You can also find information on the drug’s strength, form, and more. Medical News Today ...

DAVENPORT, Iowa (KWQC) - The Food and Drug Administration recently approved Journavx to treat short-term pain. It’s a new class of non-opioid pain medication for treating adults and the first ...